Howard Hughes Medical Institute Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
N-able
NABL
|
+$3.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Certara
CERT
|
+$12.3M |
| 2 |
SWI
SolarWinds Corporation Common Stock
SWI
|
+$4.11M |
| 3 |
DVAX
Dynavax Technologies
DVAX
|
+$210K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.66% |
| 2 | Financials | 14.21% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 8.76% |
Similar funds
Howard Hughes Medical Institute's Q3 2021 Portfolio in Review
As of Q3 2021, Howard Hughes Medical Institute held 24 positions worth $297M, down 0.8% from $299M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Howard Hughes Medical Institute withdrew a net $13.2M in Q3 2021, closing 1 position and reducing 2 holdings. Its most notable exit was Dynavax Technologies, an estimated $210K position sold in full.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Howard Hughes Medical Institute opened a new position in N-able worth $3.08M.
- Howard Hughes Medical Institute's largest Q3 2021 buy was N-able: 247,973 shares worth $3.08M.
- Howard Hughes Medical Institute's biggest Q3 2021 reduction was Certara, cutting an estimated $12.3M.
- Howard Hughes Medical Institute fully exited Dynavax Technologies in Q3 2021, selling an estimated $210K.
- Howard Hughes Medical Institute's ten largest holdings make up 75% of its $297M portfolio in Q3 2021.
- Howard Hughes Medical Institute opened 1 new position and closed 1 in Q3 2021.
- Howard Hughes Medical Institute's portfolio value fell 0.8% quarter-over-quarter to $297M.
Based on Howard Hughes Medical Institute's 13F filing for Q3 2021, filed 10 Nov 2021.